AusPAR: Rituximab
Australian Public Assessment Report
Device/Product Name
MabThera
Active ingredients
Rituximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2014-04709-1-4
Submission Type
Major variation
Decision
Approved